Dyslipidemia News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Dyslipidemia Drugs Market Top 20 Countries Data, Status, Trend, Analysis & Outlook by 2013-2023 - Investor Opinion



Dyslipidemia Drugs Market Top 20 Countries Data, Status, Trend, Analysis & Outlook by 2013-2023 
Investor Opinion
Dyslipidemia Drugs Market research report provides the Top 20 countries up-to-date industry data and industry future trends, allowing you to categorize the products and end users driving Revenue, growth and profitability. The Dyslipidemia Drugs market ...

and more » 


Global Dyslipidemia Drugs market research report with growth, latest trends & forecasts till 2022 - NB Post Gazette



Global Dyslipidemia Drugs market research report with growth, latest trends & forecasts till 2022 
NB Post Gazette
Questale released a detailed assessment of trends in Global Dyslipidemia Drugs market. The research report includes diverse topics like total market size, key market drivers, challenges, growth opportunities, key players etc. We have also covered key ...

 


Global Dyslipidemia Drugs market Research Report Released with ... - Tokenfolks (press release)



Global Dyslipidemia Drugs market Research Report Released with ... 
Tokenfolks (press release)
Questale has just released a comprehensive market research report for Global Dyslipidemia Drugs Market. This report focuses on top players in global market, with production, price, revenue and market share for each manufacturer, covering AstraZeneca ...

and more » 


Dyslipidemia Drugs Market ? AstraZeneca, Merck, Pfizer, Bayer, Abbott Laboratories, Mylan, Novartis, Amgen - First News 24



Research of Market (press release) (blog)
 
Dyslipidemia Drugs Market ? AstraZeneca, Merck, Pfizer, Bayer, Abbott Laboratories, Mylan, Novartis, Amgen 
First News 24
This report on global Dyslipidemia Drugs market analyzes the current and future prospects of the Dyslipidemia Drugs market worldwide. The stakeholders of this report include companies engaged in production and marketing of Dyslipidemia Drugs systems ...
Dyslipidemia Drugs Market Research Report 2018 to 2025 Research of Market (press release) (blog)

all 2 news articles » 


Can Dyslipidemia be Treated with Bergamot? - Medical News Bulletin



Medical News Bulletin
 
Can Dyslipidemia be Treated with Bergamot? 
Medical News Bulletin
Dyslipidemia refers to abnormal levels of triglycerides, cholesterol, or fat phospholipids in the blood. Being overweight with an elevated lipid profile is a major risk factor for cardiovascular diseases. Dyslipidemia causes vascular injury due to ...

 


Dyslipidemia Market Overview, Development, Diagnosis and Treatment for 2027 - The Financial



Dyslipidemia Market Overview, Development, Diagnosis and Treatment for 2027 
The Financial
Dyslipidemia ? Market Insights, Epidemiology and Market Forecast ? 2027?? report provides a detailed analysis of the Dyslipidemia epidemiology and market outlook for the 7MM.United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom ...

and more » 


Patients with PsA, psoriasis undertreated for CVD risk factors - Healio



Healio
 
Patients with PsA, psoriasis undertreated for CVD risk factors 
Healio
A large number of patients with psoriatic arthritis and psoriasis are underdiagnosed and go without necessary treatment for hypertension and dyslipidemia, according to findings published in the Journal of Rheumatology. ?This is one of the largest ...

 


Ace the Case: A 78-Year-Old Woman with Diabetes, Hypertension, and Dyslipidemia Presents to the ED with Chest Pain - Healio



Ace the Case: A 78-Year-Old Woman with Diabetes, Hypertension, and Dyslipidemia Presents to the ED with Chest Pain 
Healio
Type: Monograph, Articles/Items: 4. Release Date: 2/15/2018, Expiration Date: 2/14/2019. Credit Type: CME / ABIM MOC, Number of Credits: 0.25. Cost: Free, Provider: Vindico Medical Education. This ?Ace the Case? activity will utilize a case study to ...

 


Toxic Stroke Necrosis; Multivessel CAD in Diabetes; Sudden Hearing Loss - MedPage Today



MedPage Today
 
Toxic Stroke Necrosis; Multivessel CAD in Diabetes; Sudden Hearing Loss 
MedPage Today
The classic definition with a cluster of three components didn't have a significant association, but a definition by four or five of the components did. "Because metabolic syndrome is a complex condition that includes factors known to affect the onset ...

 


USPSTF: 'Yes' To Behavioral Obesity Therapy | Medpage Today - MedPage Today



MedPage Today
 
USPSTF: 'Yes' To Behavioral Obesity Therapy | Medpage Today 
MedPage Today
Group's lack of support for drug therapies draws criticism.

and more »